Back to today’s briefing

Story perspectives

Rocket Pharma Soars 11.1% on Promising Gene Therapy Results

5/19/2025

24 3

Summary

Story summary

Rocket Pharmaceuticals' gene therapy for PKP2 arrhythmogenic cardiomyopathy is making waves with promising early results, boosting safety and cardiac function. This news sent Rocket's shares soaring by 11.1%. In other developments, Harmony Energy Income Trust is gearing up for a formal auction, while BBGI Global Infrastructure sees 12.07% acceptances for Boswell Holdings' cash offer.

1 of 1

Story summary

Rocket Pharmaceuticals' gene therapy for PKP2 arrhythmogenic cardiomyopathy is making waves with promising early results, boosting safety and cardiac function. This news sent Rocket's shares soaring by 11.1%. In other developments, Harmony Energy Income Trust is gearing up for a formal auction, while BBGI Global Infrastructure sees 12.07% acceptances for Boswell Holdings' cash offer.